Shoupeng Sheng

419 total citations
15 papers, 328 citations indexed

About

Shoupeng Sheng is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Shoupeng Sheng has authored 15 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 8 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Shoupeng Sheng's work include Cancer Mechanisms and Therapy (10 papers), Peptidase Inhibition and Analysis (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Shoupeng Sheng is often cited by papers focused on Cancer Mechanisms and Therapy (10 papers), Peptidase Inhibition and Analysis (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Shoupeng Sheng collaborates with scholars based in China, United Kingdom and United States. Shoupeng Sheng's co-authors include Jiasheng Zheng, Xia Wu, Meijun Hao, Caixia Hu, Yu Sun, Long Jiang, Xicai Sun, Honghai Zhang, Cong Li and Gengxia Yang and has published in prestigious journals such as International Journal of Biological Macromolecules, BMC Cancer and Frontiers in Oncology.

In The Last Decade

Shoupeng Sheng

15 papers receiving 328 citations

Peers

Shoupeng Sheng
Greg Cohen United States
Justin Call United States
Shoupeng Sheng
Citations per year, relative to Shoupeng Sheng Shoupeng Sheng (= 1×) peers Meijun Hao

Countries citing papers authored by Shoupeng Sheng

Since Specialization
Citations

This map shows the geographic impact of Shoupeng Sheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shoupeng Sheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shoupeng Sheng more than expected).

Fields of papers citing papers by Shoupeng Sheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shoupeng Sheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shoupeng Sheng. The network helps show where Shoupeng Sheng may publish in the future.

Co-authorship network of co-authors of Shoupeng Sheng

This figure shows the co-authorship network connecting the top 25 collaborators of Shoupeng Sheng. A scholar is included among the top collaborators of Shoupeng Sheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shoupeng Sheng. Shoupeng Sheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Wang, Haiyan, Yonghong Zhang, Yu Chen, et al.. (2023). Comparison of NK cell subsets, receptors and functions induced by radiofrequency ablation and microwave ablation in HBV-associated primary hepatocellular carcinoma. Frontiers in Oncology. 13. 1048049–1048049. 1 indexed citations
2.
Zhao, Yan, Ling Qin, Guihai Liu, et al.. (2021). Distinct tumour antigen-specific T-cell immune response profiles at different hepatocellular carcinoma stages. BMC Cancer. 21(1). 1007–1007. 10 indexed citations
4.
Zheng, Jiasheng, Tian Yin, Wenwen Zhang, et al.. (2018). MiR-875-5p inhibits hepatocellular carcinoma cell proliferation and migration by repressing astrocyte elevated gene-1 (AEG-1) expression. Translational Cancer Research. 7(1). 1751–1751. 3 indexed citations
5.
Ma, Liang, et al.. (2018). Combination therapy of TACE and CT-guided partial hepatic segment ablation for liver cancer. Minimally Invasive Therapy & Allied Technologies. 27(6). 355–364. 10 indexed citations
6.
Hu, Caixia, Shichang Cui, Tian Yin, et al.. (2018). MiR-875-5p inhibits hepatocellular carcinoma cell proliferation and migration by repressing astrocyte elevated gene-1 (AEG-1) expression. Translational Cancer Research. 7(1). 158–169. 6 indexed citations
7.
Li, Cong, Xia Wu, Honghai Zhang, et al.. (2015). A Huaier polysaccharide restrains hepatocellular carcinoma growth and metastasis by suppression angiogenesis. International Journal of Biological Macromolecules. 75. 115–120. 50 indexed citations
8.
Wu, Xia, Honghai Zhang, Gengxia Yang, et al.. (2015). A Huaier polysaccharide reduced metastasis of human hepatocellular carcinoma SMMC-7721 cells via modulating AUF-1 signaling pathway. Tumor Biology. 36(8). 6285–6293. 20 indexed citations
9.
Li, Cong, Xia Wu, Wei Zhang, et al.. (2015). High-Content Functional Screening of AEG-1 and AKR1C2 for the Promotion of Metastasis in Liver Cancer. SLAS DISCOVERY. 21(1). 101–107. 12 indexed citations
10.
Li, Cong, Xia Wu, Jia Li, et al.. (2015). AEG-1 Promotes Metastasis Through Downstream AKR1C2 and NF1 in Liver Cancer. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 22(4). 203–211. 25 indexed citations
11.
Li, Cong, Xia Wu, Honghai Zhang, et al.. (2014). A Huaier polysaccharide inhibits hepatocellular carcinoma growth and metastasis. Tumor Biology. 36(3). 1739–1745. 47 indexed citations
12.
Sheng, Shoupeng, et al.. (2014). Complete remission of multiple lung metastases after ablation of hepatocellular carcinoma by transarterial infusion with the p53 gene. Anti-Cancer Drugs. 26(2). 227–231. 7 indexed citations
13.
Zheng, Jiasheng, Cong Li, Xia Wu, et al.. (2013). Huaier polysaccharides suppresses hepatocarcinoma MHCC97-H cell metastasis via inactivation of EMT and AEG-1 pathway. International Journal of Biological Macromolecules. 64. 106–110. 67 indexed citations
14.
Zheng, Jiasheng, Cong Li, Xia Wu, et al.. (2013). Astrocyte elevated gene-1 is a novel biomarker of epithelial–mesenchymal transition and progression of hepatocellular carcinoma in two China regions. Tumor Biology. 35(3). 2265–2269. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026